Citation Impact
Citing Papers
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
2005 Standout
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
Recombinant and Natural Human Interferons: Analysis of the Incidence and Clinical Impact of Neutralizing Antibodies
2011
Pharmacological properties of Salvia officinalis and its components
2017 Standout
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
2010 Standout
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
2010 Standout
Sjögren's syndrome
2005 Standout
Regulatory T cells exert checks and balances on self tolerance and autoimmunity
2009 StandoutNobel
A review of randomized controlled trials comparing the effectiveness of hand held computers with paper methods for data collection
2006
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo‐controlled study
2004
The Effectiveness of Mobile-Health Technology-Based Health Behaviour Change or Disease Management Interventions for Health Care Consumers: A Systematic Review
2013 Standout
Transient receptor potential channels: targeting pain at the source
2008 StandoutNobel
Cognitive impairment in multiple sclerosis
2008 Standout
Mucosal immunity and vaccines
2005 Standout
Preclinical safety testing of biotechnology-derived pharmaceuticals
2004
Multiple sclerosis
2008 Standout
Topical Agents in the Treatment of Rheumatic Pain
2008
Immunomodulatory Agents for the Treatment of Relapsing Multiple Sclerosis
2002
New insights into the use of currently available non-steroidal anti-inflammatory drugs
2015
Pharmacologic management of neuropathic pain: Evidence-based recommendations
2007 Standout
Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis
2003
Benefit of interferon β-1a on MSFC progression in secondary progressive MS
2002
Diagnostic criteria for multiple sclerosis
2001 Standout
The origin and application of experimental autoimmune encephalomyelitis
2007
Antigen-specific therapeutic approaches for autoimmunity
2019
Histopathology of Common Tendinopathies
1999
EFNS guideline on the treatment of tension‐type headache – Report of an EFNS task force
2010
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
2006 Standout
How smartphones are changing the face of mobile and participatory healthcare: an overview, with example from eCAALYX
2011 Standout
Multiple Sclerosis
2000 Standout
Plant-derived immunomodulators: an insight on their preclinical evaluation and clinical trials
2015 Standout
Therapeutic Approaches in Multiple Sclerosis
2002
Tendon Injury and Tendinopathy
2005 Standout
An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis
2011 Standout
New Treg cell-based therapies of autoimmune diseases: towards antigen-specific immune suppression
2020 StandoutNobel
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Interferons in relapsing remitting multiple sclerosis: a systematic review
2003
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
2004 Standout
Myelin basic protein and human coronavirus 229E cross‐reactive T cells in multiple sclerosis
1996
Multiple sclerosis
2002 Standout
Recent progress in the diagnosis and treatment of multiple sclerosis
1999
Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis
2013
Revised diagnostic criteria for neuromyelitis optica
2006 Standout
A randomized, double-blind, dose-comparison study of weekly interferon β-1a in relapsing MS
2002
Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?
2019 Standout
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study
2003 Standout
Intramuscular Interferon Beta-1A Therapy Initiated during a First Demyelinating Event in Multiple Sclerosis
2000
Effect of exercise training on quality of life in multiple sclerosis: a meta-analysis
2007 Standout
Postoperative analgesia and vomiting, with special reference to day-case surgery: a systematic review.
1998
Guideline for primary care management of headache in adults.
2015 Standout
Disease modifying therapies in multiple sclerosis: Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines [RETIRED]
2002
Works of L. D. Jacobs being referenced
Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis
1998
Self-medication of a single headache episode with ketoprofen, ibuprofen or placebo, home-monitored with an electronic patient diary
1996
Intra-articular absorption and distribution of ketoprofen after topical plaster application and oral intake in 100 patients undergoing knee arthroscopy
1999
Self‐medication of a single headache episode with ketoprofen, ibuprofen or placebo, home‐monitored with an electronic patient diary
1996
A phase I trial of solubilized DR2:MBP 84-102 (AG284) in multiple sclerosis
2000
An open, randomized study of ketoprofen in patients in surgery for Achilles or patellar tendinopathy.
1997
A double-blind, placebo-controlled trial comparing the analgesic efficacy of two formulations of diclofenac in postoperative dental pain
1992
Results of a phase III trial of IM recombinant beta interferon as treatment for MS
1994